insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

PEPL · Pepperlime Health Acquisition Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Sign in to download
AnnualQuarterly

Income Statement

Line itemQ3 '23Q2 '23Q1 '23Q4 '22Q3 '22Q2 '22Q1 '22Q4 '21Q3 '21Q2 '21
Revenue----------
Cost of Revenue----------
Gross Profit----------
R&D----------
SG&A$356.1K$46.7K$463.4K-$217.0K$278.8K$335.8K-$41.2K-
Total Operating Expenses----------
D&A----------
Operating Income($356.1K)($46.7K)($463.4K)-($217.0K)($278.8K)($335.8K)-($41.2K)-
Interest Expense----------
Income Tax----------
Net Income($207.8K)$104.4K($8.2K)-($25.7K)($46.9K)($331.4K)-($41.2K)-
EPS - Basic--------($0.01)-
EPS - Diluted--------($0.01)-

Balance Sheet

Line itemQ3 '23Q2 '23Q1 '23Q4 '22Q3 '22Q2 '22Q1 '22Q4 '21Q3 '21Q2 '21
Cash & Equivalents$248.7K$491.4K$622.5K$891.2K$1.06M$1.12M$1.24M$1.34M$4.23M$0
Accounts Receivable----------
Inventory----------
Accounts Payable--------$55.4K-
Current Assets$309.8K$676.8K$932.2K$1.26M$1.53M$1.71M$1.94M$2.13M$4.24M-
Total Assets$9.07M$13.92M$14.02M$175.40M$174.22M$173.65M$173.65M$173.83M$4.80M-
Current Liabilities$624.8K$635.6K$844.3K$703.8K$456.6K$421.6K$370.4K$224.4K$4.82M-
Long-term Debt----------
Total Liabilities$6.57M$6.59M$6.79M$6.65M$6.41M$6.37M$6.32M$6.17M--
Stockholders' Equity($6.26M)($5.91M)($5.86M)($5.40M)($4.88M)($4.66M)($4.37M)($4.04M)($16.2K)$0
Retained Earnings($6.27M)($5.91M)($5.86M)($5.40M)($4.88M)($4.66M)($4.38M)($4.04M)($41.2K)-

Cash Flow

Line itemQ3 '23Q2 '23Q1 '23Q4 '22Q3 '22Q2 '22Q1 '22Q4 '21Q3 '21Q2 '21
Operating Cash Flow--($268.6K)---($105.2K)-($546)-
Investing Cash Flow--$0-------
Financing Cash Flow--($161.51M)-----$4.24M-
CapEx----------
Free Cash Flow----------

Ratios

MetricQ3 '23Q2 '23Q1 '23Q4 '22Q3 '22Q2 '22Q1 '22Q4 '21Q3 '21Q2 '21
Profitability
Gross margin----------
Operating margin----------
EBITDA margin----------
Net margin----------
Free cash flow margin----------
FCF / Net income----------
R&D / Revenue----------
SG&A / Revenue----------
Effective tax rate----------
Return on assets-2.3%0.7%-0.1%--0.0%-0.0%-0.2%--0.9%-
Return on equity3.3%-1.8%0.1%-0.5%1.0%7.6%-254.0%-
Return on invested capital----------
Liquidity
Current ratio0.501.061.101.783.354.065.249.490.88-
Quick ratio0.501.061.101.783.354.065.249.490.88-
Cash ratio0.400.770.741.272.322.653.345.980.88-
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage----------
Equity multiplier-1.45-2.36-2.39-32.49-35.72-37.26-39.69-42.99-295.88-
Liabilities / Assets0.720.470.480.040.040.040.040.04--
Efficiency
Asset turnover----------
Inventory turnover----------
Days sales outstanding----------
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E----------
P / B----------
P / S----------
EV / EBITDA----------
Growth
Revenue growth (YoY)----------
Revenue CAGR (3y)----------
Revenue CAGR (5y)----------
Gross profit growth (YoY)----------
Operating income growth (YoY)-64.1%83.3%-38.0%--426.2%-----
Net income growth (YoY)-707.9%-97.5%-37.6%-----
EPS growth (YoY)----------
EPS CAGR (3y)----------
EPS CAGR (5y)----------
FCF growth (YoY)----------
FCF CAGR (5y)----------
Book value growth (YoY)-28.5%-26.8%-34.0%-33.5%-29948.8%-----

Peer comparison

Same SIC group: Blank Checks

CompanyRevenue (last FY)Net marginROE
ISPO---
INV$2.06M-14266.4%-143.6%
IEA$2.08B-4.0%-224.7%
TWOA---42.8%
BOCN---

Comparing PepperLime Health Acquisition Corp against the 5 most active filers in the same SIC group.